文献速递腹部技术与安全CT

基于增强CT的多模态模型预测腹膜后脂肪肉瘤切除后总生存:双中心回顾性研究

Contrast-enhanced CT-based multimodal modeling for overall survival prediction after resection of retroperitoneal liposarcoma: a bicentric retrospective study.
PubMed 文献 · Abdom Radiol (NY) · 2026-10-27

本研究纳入367例完全切除的腹膜后脂肪肉瘤患者,利用术前增强CT的影像组学与深度学习特征联合术后临床病理信息构建RDCS模型预测总生存。RDCS在训练集、内部验证集和外部测试集的C指数分别为0.775、0.704和0.725,均高于单一模型;外部原发肿瘤亚组中RDCS的C指数为0.746,高于Sarculator的0.590。

要点

  • RDCS模型整合术前CT影像特征与术后临床病理信息,可辅助评估RPLS术后总生存。
  • 外部测试集C指数0.725,原发肿瘤亚组中优于Sarculator(0.746 vs 0.590)。
  • 模型应用仍需前瞻性验证和临床影响评估,目前定位为补充现有工具。

核心结论

  • RDCS模型利用术前CT影像特征和术后临床病理信息可估计完全切除RPLS后的总生存,可能补充现有术后预后工具。

研究设计与样本

  • 双中心回顾性研究,纳入2009至2021年367例完全切除RPLS患者,机构1提供训练集128例和内部验证集55例,机构2提供外部测试集184例。
  • 影像组学特征基于三维肿瘤特征构建,深度学习特征基于最大轴位肿瘤层面、ImageNet预训练ResNet-101并以Cox偏似然损失训练。
  • 临床变量经单因素和多因素Cox回归筛选,保留的临床病理变量与影像特征整合为RDCS模型。

诊断标准与关键数值

  • 训练集、内部验证集和外部测试集RDCS的C指数分别为0.775、0.704和0.725,均高于单独的影像组学、深度学习和临床模型。
  • 外部原发肿瘤亚组(n=82)中RDCS的C指数为0.746,官方Sarculator应用为0.590。
  • 校准曲线显示预测生存与实际观察生存一致,决策曲线分析提示在所评估阈值内具有潜在临床效用。

临床应用与阅片要点

  • 术前增强CT可提取影像组学和深度学习特征,结合术后病理信息用于RPLS术后生存风险分层。
  • 在报告或 multidisciplinary 讨论中,可将RDCS作为现有预后工具的补充参考,而非替代。
  • 注意模型输出需结合临床,目前尚不推荐直接用于改变随访或治疗决策。

局限性

  • 回顾性设计,样本来自两个中心。
  • 作者指出需前瞻性验证和临床影响评估后才能用于监测和临床管理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: Postoperative risk estimation in retroperitoneal liposarcoma (RPLS) remains challenging because conventional clinicopathologic models capture only part of its biological heterogeneity. We aimed to develop and externally evaluate a postoperative prognostic model integrating preoperative CT features with postoperative clinicopathologic information to estimate overall survival (OS) after RPLS resection.

MATERIALS AND METHODS: This bicentric retrospective study included 367 patients who underwent complete RPLS resection between 2009 and 2021. Institution 1 provided the training cohort (n = 128) and internal validation cohort (n = 55); Institution 2 provided the external test cohort (n = 184). A radiomics signature was constructed from three-dimensional tumor features. A deep-learning signature was derived from the largest axial tumor section using an ImageNet-pretrained ResNet-101 trained with Cox partial-likelihood loss. Clinical variables underwent univariable and multivariable Cox regression analysis. The retained clinicopathologic variables and imaging signatures were integrated into a combined model termed RDCS.

RESULTS: During follow-up, 71, 30, and 107 patients died in the training, internal validation, and external test cohorts, respectively. The corresponding RDCS C-indices were 0.775, 0.704, and 0.725, each higher than those of the individual radiomics, deep-learning, and clinical models. Calibration curves showed agreement between predicted and observed survival. Decision-curve analysis suggested potential clinical utility within the evaluated thresholds. In a separate exploratory comparison in the external primary-tumor subset (n = 82), C-indices were 0.746 for RDCS and 0.590 for the official Sarculator application.

CONCLUSION: RDCS estimates OS after complete RPLS resection using preoperative CT-derived imaging signatures and postoperative clinicopathologic information. RDCS may complement established postoperative prognostic tools, but its application in surveillance and clinical management requires prospective validation and clinical impact assessment.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Fan P, Zhang J, Luo W, et al. Contrast-enhanced CT-based multimodal modeling for overall survival prediction after resection of retroperitoneal liposarcoma: a bicentric retrospective study. Abdom Radiol (NY). 2026. PMID: 42944909. doi:10.1007/s00261-026-05846-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。